美国Cytonome Inc.

Cytonome Inc. develops, manufactures, and markets clinical grade optical cell sorting technology. Cytonome's Gigasort system is the only clinical grade, cGMP compliant optical cell sorter built around a closed, sterile and disposable cartridge to guarantee operator safety and sample isolation. Cytonome's revolutionary technology can be used for the precise and safe selection of discrete cell subpopulations. Gigasort™ technology has been designed for use in cGMP cell production environments where investigators wish to transition pre-clinical protocols to clinical production and develop new cell therapy inventions. The Gigasort™ cell sorter will enable a broad array of cell and gene therapies, including new treatments for cancer, autoimmune disease and regenerative medicine applications.

At Cytonome, we strive to provide our customers with the finest science, customer service and innovation and welcome collaborative inquiries. Cytonome was founded in 2002 and is headquartered in Boston, Massachusetts.

Our Mission:

Cytonome's mission is to provide technology to our customers to enable the development of novel cell therapy protocols and treatments.

Cytonome's guiding business practices:

• We collaborate openly with our partners regarding potential cellular therapies and respond to our customer's needs.
• We market the most advanced, highest quality cell sorters available worldwide and manufacture our products under the strictest quality control guidelines suitable for cGMP environments.
• We operate under the highest standards of ethics.